ETF Managers Group’s Moderna MRNA Stock Holding History

ETF Managers Group’s Portfolio MRNA Stock Details MRNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	$1.29M	Buy	8,410 +2,932	+54%	+$484K	0.04%	174
2022 Q4	$984K	Sell	5,478 -36,789	-87%	-$6.02M	0.05%	154
2022 Q3	$5M	Buy	42,267 +31,429	+290%	+$4.77M	0.16%	110
2022 Q2	$1.55M	Sell	10,838 -3,133	-22%	-$448K	0.04%	187
2022 Q1	$2.44M	Sell	13,971 -21,559	-61%	-$3.63M	0.05%	190
2021 Q4	$8.94M	Buy	35,530 +17,104	+93%	+$5M	0.18%	134
2021 Q3	$6.98M	Buy	18,426 +1,862	+11%	+$687K	0.13%	141
2021 Q2	$3.88M	Sell	16,564 -38,565	-70%	-$6.89M	0.06%	160
2021 Q1	$6.53M	Buy	55,129 +1,701	+3%	+$246K	0.12%	133
2020 Q4	$5.94M	Sell	53,428 -14,946	-22%	-$1.51M	0.13%	121
2020 Q3	$4.82M	Buy	68,374 +24,884	+57%	+$1.73M	0.15%	113
2020 Q2	$2.7M	Sell	43,490 -3,688	-8%	-$202K	0.1%	125
2020 Q1	$1.44M	Buy	+47,178	New	+$1.09M	0.07%	135

Other funds holding MRNA

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Flagship Pioneering Cambridge, Massachusetts $1.54B AUM 86.39% 1-Year Est. Return

Coatue Management New York $48.6B AUM 94.27% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Theleme Partners London, United Kingdom $1.68B AUM 19.9% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

ETF Managers Group's MRNA Position: Q1 2023 in Review

ETF Managers Group increased its Moderna (MRNA) stake by 54% in Q1 2023, buying an estimated $484K and bringing the position to 8,410 shares worth $1.29M. The position accounts for 0.04% of the portfolio, ranked #174.

ETF Managers Group first reported a position in MRNA in Q1 2020 and has held it in 13 quarters since. The position peaked at $8.94M in Q4 2021. 1,016 funds tracked by Wall St. Rank hold MRNA as of Q1 2023.

ETF Managers Group held 8,410 shares of Moderna worth $1.29M as of Q1 2023.
ETF Managers Group bought 2,932 Moderna shares in Q1 2023, an estimated $484K.
Moderna made up 0.04% of ETF Managers Group's portfolio in Q1 2023, its #174 holding.
ETF Managers Group first reported a position in Moderna in Q1 2020 and has held it in 13 quarters since.
ETF Managers Group's Moderna position peaked at $8.94M in Q4 2021.
1,016 funds tracked by Wall St. Rank held Moderna as of Q1 2023.

Based on ETF Managers Group's 13F filing for Q1 2023, filed 18 Apr 2023.